Keryx Biopharmaceuticals Appoints VP, Marketing And Strategy
Executive Summary
Keryx Biopharmaceuticals Inc., a biopharma specialising in the treatment of renal disease, has appointed Douglas Jermasek vice president of marketing and strategy. Jermasek has more than 20 years of biopharma strategic marketing experience, having held senior leadership roles at several companies, including Deltanoid Pharmaceuticals, Intercept Pharmaceuticals and Genzyme/Sanofi’s global renal business, where he reached the position of senior vice president and general manager.